Functional outcome of prolonged refractory status epilepticus

被引:38
作者
Lai, Alexandre [1 ]
Outin, Herve D. [2 ]
Jabot, Julien [3 ]
Megarbane, Bruno [4 ]
Gaudry, Stephane [5 ,6 ]
Coudroy, Remi [7 ]
Louis, Guillaume [8 ]
Schneider, Francis [9 ]
Barbarot, Nicolas [10 ]
Roch, Antoine [11 ]
Lerolle, Nicolas [12 ]
Luis, David [13 ]
Fourrier, Francois [14 ]
Renault, Anne [15 ]
Argaud, Laurent [16 ]
Sharshar, Tarek [17 ]
Gibot, Sebastien [1 ]
Bollaert, Pierre-Edouard [1 ]
机构
[1] CHU Nancy, Hop Cent, Serv Reanimat Med, Nancy, France
[2] CHI Poissy St Germain Laye, Serv Reanimat Med Chirurg, Poissy, France
[3] CHU Reunion, Serv Reanimat Polyvalente, St Denis, Reunion, France
[4] Univ Paris 06, CHU Lariboisiere, Serv Reanimat & Toxicol, Paris, France
[5] Hop Louis Mourier, Serv Reanimat Med Chirurg, F-92701 Colombes, France
[6] Univ Paris Diderot, UMRS 1123, Paris, France
[7] CHU Poitiers, Serv Reanimat Med, Poitiers, France
[8] CHR Metz Thionville, Serv Reanimat Polyvalente, Metz, France
[9] Univ Louis Pasteur Strasbourg 1, Hop Strasbourg Hautepierre, Serv Reanimat Med, Strasbourg, France
[10] CH St Brieuc, Serv Reanimat Polyvalente, St Brieuc, France
[11] CHU Marseille, Hop Nord, Serv Reanimat, Marseille, France
[12] Univ Angers, CHU, Serv Reanimat Med & Med Hyperbare, Angers, France
[13] Serv Reanimat Med Chirurg, Garches, France
[14] CHU Lille, Hop Roger Salengro, Serv Reanimat Polyvalente, F-59037 Lille, France
[15] CHU Brest, Serv Reanimat Med, F-29285 Brest, France
[16] Hop Edouard Herriot, Serv Reanimat Med, Lyon, France
[17] Univ Versailles St Quentin Yvelines, Hop Raymond Poincare, Serv Reanimat Med Chirurg, Garches, France
来源
CRITICAL CARE | 2015年 / 19卷
关键词
CONVULSIVE STATUS EPILEPTICUS; VASOPRESSOR USE; MANAGEMENT; PREDICTORS; FREQUENCY; PROGNOSIS; THERAPY; IMPACT; RISK;
D O I
10.1186/s13054-015-0914-9
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: To characterize etiology, clinical course and outcomes of patients in prolonged refractory status epilepticus (PRSE) and looking for prognostic factors. Methods: Retrospective study conducted in patients hospitalized from January 1, 2001 to December 31, 2011 in 19 polyvalent intensive care units in French university and general hospitals. Patients were adults with a generalized convulsive refractory status epilepticus that lasted more than seven days, despite treatment including an anesthetic drug and mechanical ventilation. Patients with anoxic encephalopathy were excluded. Follow-up phone call was used to determine functional outcome using modified Rankin Scale (mRS) with mRS 0-3 defining good and mRS 4-6 poor outcome. Results: 78 patients (35 female) were included. Median age was 57 years. Causes of status epilepticus were various, mainly including prior epilepsy (14.1%), CNS infection (12.8%), and stroke (12.8%). No etiology was found in 27 (34.6%) patients. PRSE was considered controlled in only 53 (67.9%) patients after a median duration of 17 (IQR 12-26) days. The median length of ICU stay was 28 (19-48) days. Forty-one (52.5%) patients died in the ICU, 26 from multiple organ failure, 8 from care withdrawal, 2 from sudden cardiac arrest, 1 from brain death and 4 from unknown causes. PRSE was previously resolved in 20 patients who died in the ICU. At one-year follow-up, there were 12 patients with good outcome and 58 with poor outcome and 8 lost of follow-up. On multivariate analysis, only vasopressor use was a predictor of poor outcome (OR 6.54; 95%CI 1.09-39.29; p = 0.04). Conclusion: Poor outcome was observed in about 80% of this population of PRSE. Most patients died from systemic complications linked to their ICU stay. Some patients can recover satisfactorily over time though we did not identify any robust factor of good outcome.
引用
收藏
页数:7
相关论文
共 29 条
  • [1] Refractory status epilepticus
    Bleck, TP
    [J]. CURRENT OPINION IN CRITICAL CARE, 2005, 11 (02) : 117 - 120
  • [2] Guidelines for the Evaluation and Management of Status Epilepticus
    Brophy, Gretchen M.
    Bell, Rodney
    Claassen, Jan
    Alldredge, Brian
    Bleck, Thomas P.
    Glauser, Tracy
    LaRoche, Suzette M.
    Riviello, James J., Jr.
    Shutter, Lori
    Sperling, Michael R.
    Treiman, David M.
    Vespa, Paul M.
    [J]. NEUROCRITICAL CARE, 2012, 17 (01) : 3 - 23
  • [3] Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: A systematic review
    Claassen, J
    Hirsch, LJ
    Emerson, RG
    Mayer, SA
    [J]. EPILEPSIA, 2002, 43 (02) : 146 - 153
  • [4] Cooper AD, 2009, ARCH NEUROL-CHICAGO, V66, P1505, DOI 10.1001/archneurol.2009.273
  • [5] DODSON WE, 1993, JAMA-J AM MED ASSOC, V270, P854
  • [6] Vasopressor Use in Adult Patients
    Ferguson-Myrthil, Nadia
    [J]. CARDIOLOGY IN REVIEW, 2012, 20 (03) : 153 - 158
  • [7] Refractory status epilepticus What to put down: The anesthetics or the patient?
    Fountain, Nathan B.
    Fugate, Jennifer E.
    [J]. NEUROLOGY, 2014, 82 (08) : 650 - 651
  • [8] Predictors of Outcome in Refractory Status Epilepticus
    Hocker, Sara E.
    Britton, Jeffrey W.
    Mandrekar, Jayawant N.
    Wijdicks, E. F. M.
    Rabinstein, Alejandro A.
    [J]. JAMA NEUROLOGY, 2013, 70 (01) : 72 - 77
  • [9] Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit
    Holtkamp, M
    Othman, J
    Buchheim, K
    Meierkord, H
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (04) : 534 - 539
  • [10] ANTI-NMDA RECEPTOR ENCEPHALITIS CAUSING PROLONGED NONCONVULSIVE STATUS EPILEPTICUS
    Johnson, Nicholas
    Henry, Craig
    Fessler, A. James
    Dalmau, Josep
    [J]. NEUROLOGY, 2010, 75 (16) : 1480 - 1482